{"id":3484,"date":"2017-02-08T07:30:00","date_gmt":"2017-02-08T07:30:00","guid":{"rendered":"https:\/\/chromogenics.dev.phosdev.se\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/"},"modified":"2021-12-09T12:03:32","modified_gmt":"2021-12-09T12:03:32","slug":"chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt","status":"publish","type":"post","link":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/","title":{"rendered":"ChromoGenics ans\u00f6ker om notering p\u00e5 Nasdaq First North och offentligg\u00f6r prospekt"},"content":{"rendered":"<p><em>EJ F\u00d6R PUBLICERING, DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, JAPAN ELLER N\u00c5GON ANNAN JURISDIKTION D\u00c4R DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE SKULLE VARA OTILL\u00c5TEN ENLIGT TILL\u00c4MPLIG LAG. SE \u00c4VEN AVSNITTET VIKTIG INFORMATION NEDAN. <\/em><\/p>\n<p><strong>ChromoGenics AB (publ), en ledare inom dynamiska glas, har beslutat att ans\u00f6ka om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission till institutionella investerare och allm\u00e4nheten i Sverige p\u00e5 117 miljoner kronor.<\/strong><\/p>\n<p>Prospekt finns att ladda ner via <a href=\"https:\/\/chromogenics.com\/\">ChromoGenics<\/a>, <a href=\"https:\/\/gwkapital.se\" target=\"_blank\" rel=\"noopener nofollow\">GW Kapital<\/a> samt <a href=\"https:\/\/aktieinvest.se\" target=\"_blank\" rel=\"noopener nofollow\">Aktieinvest<\/a> eller kan best\u00e4llas i tryckt format fr\u00e5n G&amp;W Fondkommission p\u00e5 <a href=\"mailto:info@gwkapital.se\" target=\"_blank\" rel=\"noopener\">info@gwkapital.se<\/a> eller per telefon p\u00e5 08\/503 000 50.<\/p>\n<p>&nbsp;<\/p>\n<h2>OM CHROMOGENICS OCH ERBJUDANDET<\/h2>\n<p>ChromoGenics erbjuder dynamiska glas med kontrollerbara optiska egenskaper. Bolagets unika elektrokroma teknologi, ConverLight\u2122, ger dynamiskt solskydd med \u00f6kad inomhuskomfort och energieffektivitet. Teknologin har sin grund i v\u00e4rldsledande forskning p\u00e5 \u00c5ngstr\u00f6mlaboratoriet vid Uppsala universitet.<\/p>\n<p>Under 2016 p\u00e5b\u00f6rjades kommersiell f\u00f6rs\u00e4ljning och leveranser till fastighetsprojekt i Skandinavien, vilken estimeras forts\u00e4tta v\u00e4xa under 2017 med stigande volymf\u00f6rs\u00e4ljning och resultatf\u00f6rb\u00e4ttring p\u00e5f\u00f6ljande \u00e5r.<\/p>\n<p>Marknaden f\u00f6r dynamiska glas f\u00f6rv\u00e4ntas v\u00e4xa kraftigt kommande \u00e5r enligt det amerikanska analysf\u00f6retaget n-tech Research. \u201dChromoGenics kommer med stor sannolikhet att bidra v\u00e4sentligt till den installerade basen av elektrokroma f\u00f6nster f\u00f6r kommersiella byggnader fram\u00f6ver, men har precis bara b\u00f6rjat upprampning av produktion\u201d &#8211; n-tech Research on smart windows markets: 2016-2025, Nov 2016.<\/p>\n<p>\u201cChromoGenics \u00e4r en ledande leverant\u00f6r av dynamiskt glas f\u00f6r f\u00f6nster, fasader och tak till kommersiella fastigheter. V\u00e5r produkt ConverLight\u2122 g\u00f6r fastigheter mer attraktiva genom h\u00f6gteknologiskt solskydd som ger \u00f6kad inomhuskomfort och energieffektivitet samt l\u00e4gre underh\u00e5llskostnader\u201d inleder Thomas Almesj\u00f6, VD f\u00f6r ChromoGenics.<\/p>\n<p>\u201cEfter omfattande investeringar i innovation och utveckling \u00e4r v\u00e5r produkt nu i b\u00f6rjan av en sp\u00e4nnande kommersialiseringsfas. Produkten \u00e4r h\u00e5llbar och kostnadseffektiv, vilket g\u00f6r den till ett mycket konkurrenskraftigt substitut till markiser och andra externa solskydd. Vi har under de senaste \u00e5ren utvecklat verksamheten, etablerat storskalig produktion och v\u00e5r huvudfokus \u00e4r nu kunder, kvalitet och leveransprecision. Listningen inneb\u00e4r att vi kan forts\u00e4tta utveckla v\u00e5r produkt, expandera v\u00e5r verksamhet och st\u00e4rka v\u00e5rt erbjudande till kunder och \u00f6vriga intressenter.\u201d avslutar Thomas Almesj\u00f6.<\/p>\n<p>Erbjudandet uppg\u00e5r till maximalt ca 117 MSEK plus en eventuell \u00f6vertilldelning om maximalt ca 13 MSEK. Emissionsbeloppet \u00e4r garanterat upp till ca 96 MSEK genom dels teckningsf\u00f6rbindelser fr\u00e5n huvud\u00e4garna K-Svets Venture AB och New Energy Solutions II K\/S samt ett konsortium av st\u00f6rre investerare om totalt ca 55 MSEK och dels genom teckningsgarantier om ca 41 MSEK fr\u00e5n ett antal st\u00f6rre investerare.<\/p>\n<p>Nettoemissionslikviden kommer att anv\u00e4ndas till att intensifiera f\u00f6rs\u00e4ljnings- och marknadsaktiviteter samt fortsatt produktutveckling och investering i produktionsutrustning f\u00f6r att \u00f6ka kapaciteten. Den kommer \u00e4ven att anv\u00e4ndas till att finansiera r\u00f6relsekapitalbehov och f\u00f6rst\u00e4rka balansr\u00e4kningen i syfte att accelerera den planerade expansionen.<\/p>\n<p>F\u00f6rsta dag f\u00f6r handel planeras till den 23 mars 2017 f\u00f6rutsatt att ChromoGenics godk\u00e4nns av First North f\u00f6r upptagande till handel, vilket bl a inneb\u00e4r att spridningskravet ska uppfyllas. Teckningstiden p\u00e5g\u00e5r mellan 9 och 24 februari 2017.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>R\u00c5DGIVARE\u00a0 <\/strong><br \/>\nG&amp;W Fondkommission \u00e4r finansiell r\u00e5dgivare i samband med erbjudandet och kommer att vara bolagets Certified Adviser p\u00e5 First North. Hannes Snellman Advokatbyr\u00e5 AB \u00e4r legal r\u00e5dgivare avseende svensk r\u00e4tt till ChromoGenics i samband med erbjudandet.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>F\u00d6R MER INFORMATION<\/strong>:<\/h3>\n<p>Thomas Almesj\u00f6, VD<br \/>\nSusanne Andersson, CFO &amp; kommunikationschef<br \/>\n+46 (0)18 430 04 30<br \/>\n<a href=\"mailto:info@chromogenics.com\" target=\"_blank\" rel=\"noopener\"> info@chromogenics.com<\/a><\/p>\n<h3><strong><br \/>\nVIKTIG INFORMATION<\/strong><\/h3>\n<p>Detta dokument har inte blivit godk\u00e4nt av n\u00e5gon regulatorisk myndighet. Dokumentet \u00e4r ett pressmeddelande och inte ett prospekt och investerare ska inte teckna eller k\u00f6pa v\u00e4rdepapper som avses i detta dokument f\u00f6rutom p\u00e5 grundval av den information som finns i det prospekt som har godk\u00e4nts av Finansinspektionen och kommer h\u00e5llas tillg\u00e4ngligt p\u00e5 bolagets hemsida. Distributionen av detta pressmeddelande kan i vissa jurisdiktioner vara f\u00f6rem\u00e5l f\u00f6r restriktioner enligt lag och personer som f\u00e5r tillg\u00e5ng till detta, eller del av detta, b\u00f6r informera sig om och f\u00f6lja s\u00e5dana legala restriktioner. Informationen i detta pressmeddelande ska inte utg\u00f6ra ett erbjudande om att s\u00e4lja aktier eller en uppmaning om att k\u00f6pa aktier, inte heller ska det ske n\u00e5gon f\u00f6rs\u00e4ljning av de v\u00e4rdepapper vilka refereras till h\u00e4ri, i n\u00e5gon jurisdiktion d\u00e4r ett s\u00e5dant erbjudande, uppmaning om att k\u00f6pa eller f\u00f6rs\u00e4ljning skulle kr\u00e4va framtagande av ytterligare prospekt eller annan erbjudandehandling, eller inte skulle vara lagenlig utan registrering eller till\u00e4mpligt undantag fr\u00e5n registrering enligt v\u00e4rdepapperslagarna i s\u00e5dan jurisdiktion.<\/p>\n<p>Detta pressmeddelande varken utg\u00f6r, eller utg\u00f6r en del av, ett erbjudande eller en uppmaning om ett erbjudande att k\u00f6pa eller teckna v\u00e4rdepapper i USA. V\u00e4rdepapperna omn\u00e4mnda h\u00e4ri har inte och kommer inte registreras i enlighet med den amerikanska Securities Act fr\u00e5n 1933 (\u201dSecurities Act\u201d), och f\u00e5r inte erbjudas eller s\u00e4ljas i USA utan registrering i enlighet med Securities Act eller ett d\u00e4rtill relaterat undantag. V\u00e4rdepapper omn\u00e4mnda h\u00e4ri erbjuds inte till allm\u00e4nheten i USA. Kopior av detta pressmeddelande g\u00f6rs inte och f\u00e5r inte distribueras eller skickas, i sin helhet eller delvis, direkt eller indirekt, till Australien, Hong Kong, Japan, Kanada, Nya Zeeland, Schweiz, Singapore, Sydafrika eller USA eller till n\u00e5gon annan jurisdiktion d\u00e4r distributionen respektive utskicket av detta pressmeddelande skulle vara olagligt.<\/p>\n<p>ChromoGenics \u00e4r en global ledare inom dynamiska glas med kontrollerbara optiska egenskaper. Bolagets unika elektrokroma teknologi, ConverLight\u2122, ger dynamiskt solskydd med \u00f6kad inomhuskomfort och energieffektivitet. Under 2016 p\u00e5b\u00f6rjades f\u00f6rs\u00e4ljning och leveranser till fastighetsprojekt i Skandinavien.<\/p>\n<p>ChromoGenics \u00e4r baserat i Uppsala och h\u00e4rstammar fr\u00e5n v\u00e4rldsledande forskning p\u00e5 \u00c5ngstr\u00f6mlaboratoriet vid Uppsala universitet. Bolaget har cirka 20 anst\u00e4llda och de huvudsakliga \u00e4garna \u00e4r K-Svets Venture AB och New Energy Solutions II K\/S. Bolagets produktionsanl\u00e4ggning har delvis finansierats med ett villkorsl\u00e5n fr\u00e5n Energimyndigheten.<\/p>\n<p><a href=\"https:\/\/chromogenics.com\/\">ChromoGenics<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p class=\"\"><a title=\"Pressmeddelande (PDF)\" href=\"https:\/\/mb.cision.com\/Main\/15418\/2182475\/625020.pdf\" target=\"_blank\" rel=\"noopener nofollow\">Pressmeddelande (PDF)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EJ F\u00d6R PUBLICERING, DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, JAPAN ELLER N\u00c5GON ANNAN JURISDIKTION D\u00c4R DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE SKULLE VARA OTILL\u00c5TEN ENLIGT TILL\u00c4MPLIG LAG. SE \u00c4VEN AVSNITTET VIKTIG INFORMATION NEDAN.<\/p>\n","protected":false},"author":1,"featured_media":3225,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-3484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressmeddelanden","category-37","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ans\u00f6kning om notering p\u00e5 Nasdaq First North - ChromoGenics<\/title>\n<meta name=\"description\" content=\"ChromoGenics ans\u00f6ker om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission p\u00e5 117 miljoner kronor.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ans\u00f6kning om notering p\u00e5 Nasdaq First North - ChromoGenics\" \/>\n<meta property=\"og:description\" content=\"ChromoGenics ans\u00f6ker om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission p\u00e5 117 miljoner kronor.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/\" \/>\n<meta property=\"og:site_name\" content=\"ChromoGenics AB\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chromogenics\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-08T07:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-09T12:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"388\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ChromogenicsAB\" \/>\n<meta name=\"twitter:site\" content=\"@ChromogenicsAB\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/person\\\/7c92fbbac1b88b2f60e31659cd8fdc82\"},\"headline\":\"ChromoGenics ans\u00f6ker om notering p\u00e5 Nasdaq First North och offentligg\u00f6r prospekt\",\"datePublished\":\"2017-02-08T07:30:00+00:00\",\"dateModified\":\"2021-12-09T12:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/\"},\"wordCount\":1049,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/\",\"name\":\"Ans\u00f6kning om notering p\u00e5 Nasdaq First North - ChromoGenics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"datePublished\":\"2017-02-08T07:30:00+00:00\",\"dateModified\":\"2021-12-09T12:03:32+00:00\",\"description\":\"ChromoGenics ans\u00f6ker om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission p\u00e5 117 miljoner kronor.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#primaryimage\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"contentUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"width\":500,\"height\":388,\"caption\":\"ChromoGenics logo over faded white background\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChromoGenics ans\u00f6ker om notering p\u00e5 Nasdaq First North och offentligg\u00f6r prospekt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#website\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/\",\"name\":\"ChromoGenics AB\",\"description\":\"The performance glass pioneers\",\"publisher\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#organization\",\"name\":\"ChromoGenics AB\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/ChromoGenics-AB-logo-black.jpeg\",\"contentUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/ChromoGenics-AB-logo-black.jpeg\",\"width\":1920,\"height\":1080,\"caption\":\"ChromoGenics AB\"},\"image\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chromogenics\",\"https:\\\/\\\/x.com\\\/ChromogenicsAB\",\"https:\\\/\\\/www.instagram.com\\\/chromogenicsab\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/chromogenics-ab\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkeqSnhvjErkRgFJo9eBx9Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/person\\\/7c92fbbac1b88b2f60e31659cd8fdc82\",\"name\":\"admin\",\"sameAs\":[\"https:\\\/\\\/chromogenics.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ans\u00f6kning om notering p\u00e5 Nasdaq First North - ChromoGenics","description":"ChromoGenics ans\u00f6ker om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission p\u00e5 117 miljoner kronor.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/","og_locale":"sv_SE","og_type":"article","og_title":"Ans\u00f6kning om notering p\u00e5 Nasdaq First North - ChromoGenics","og_description":"ChromoGenics ans\u00f6ker om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission p\u00e5 117 miljoner kronor.","og_url":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/","og_site_name":"ChromoGenics AB","article_publisher":"https:\/\/www.facebook.com\/chromogenics","article_published_time":"2017-02-08T07:30:00+00:00","article_modified_time":"2021-12-09T12:03:32+00:00","og_image":[{"width":500,"height":388,"url":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@ChromogenicsAB","twitter_site":"@ChromogenicsAB","twitter_misc":{"Skriven av":"admin","Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#article","isPartOf":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/"},"author":{"name":"admin","@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/person\/7c92fbbac1b88b2f60e31659cd8fdc82"},"headline":"ChromoGenics ans\u00f6ker om notering p\u00e5 Nasdaq First North och offentligg\u00f6r prospekt","datePublished":"2017-02-08T07:30:00+00:00","dateModified":"2021-12-09T12:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/"},"wordCount":1049,"commentCount":0,"publisher":{"@id":"https:\/\/chromogenics.com\/sv\/#organization"},"image":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#primaryimage"},"thumbnailUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/","url":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/","name":"Ans\u00f6kning om notering p\u00e5 Nasdaq First North - ChromoGenics","isPartOf":{"@id":"https:\/\/chromogenics.com\/sv\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#primaryimage"},"image":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#primaryimage"},"thumbnailUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","datePublished":"2017-02-08T07:30:00+00:00","dateModified":"2021-12-09T12:03:32+00:00","description":"ChromoGenics ans\u00f6ker om en notering p\u00e5 Nasdaq First North. I samband med noteringen genomf\u00f6rs en nyemission p\u00e5 117 miljoner kronor.","breadcrumb":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#primaryimage","url":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","contentUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","width":500,"height":388,"caption":"ChromoGenics logo over faded white background"},{"@type":"BreadcrumbList","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-ansoker-om-notering-pa-nasdaq-first-north-och-offentliggor-prospekt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chromogenics.com\/sv\/"},{"@type":"ListItem","position":2,"name":"ChromoGenics ans\u00f6ker om notering p\u00e5 Nasdaq First North och offentligg\u00f6r prospekt"}]},{"@type":"WebSite","@id":"https:\/\/chromogenics.com\/sv\/#website","url":"https:\/\/chromogenics.com\/sv\/","name":"ChromoGenics AB","description":"The performance glass pioneers","publisher":{"@id":"https:\/\/chromogenics.com\/sv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chromogenics.com\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/chromogenics.com\/sv\/#organization","name":"ChromoGenics AB","url":"https:\/\/chromogenics.com\/sv\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/logo\/image\/","url":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/09\/ChromoGenics-AB-logo-black.jpeg","contentUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/09\/ChromoGenics-AB-logo-black.jpeg","width":1920,"height":1080,"caption":"ChromoGenics AB"},"image":{"@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chromogenics","https:\/\/x.com\/ChromogenicsAB","https:\/\/www.instagram.com\/chromogenicsab\/","https:\/\/www.linkedin.com\/company\/chromogenics-ab\/","https:\/\/www.youtube.com\/channel\/UCkeqSnhvjErkRgFJo9eBx9Q"]},{"@type":"Person","@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/person\/7c92fbbac1b88b2f60e31659cd8fdc82","name":"admin","sameAs":["https:\/\/chromogenics.com"]}]}},"_links":{"self":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/posts\/3484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/comments?post=3484"}],"version-history":[{"count":0,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/posts\/3484\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/media\/3225"}],"wp:attachment":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/media?parent=3484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/categories?post=3484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/tags?post=3484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}